Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
LONDON — The U.K.'s health regulator on Tuesday approved the use of Novo Nordisk's Wegovy weight loss drug to reduce the risk of overweight and obese adults suffering from serious heart problems or strokes.